Home > PE Ratio > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of SENORES PHARMACEUTICALS is 48.13.

Share Price ₹1,269.0Jun 25,2026
Market Cap ₹5,849.9 Cr
Earnings-TTM₹121.6 CrTTM-Consolidated Results
Price/Earnings48.13xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SENORES PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SENORES PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹5,849.9 Cr] as on Jun 25,2026

(/) Earnings [ ₹121.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 48.13x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SENORES PHARMACEUTICALS , the investors are currently willing to pay 48.13 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SENORES PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SENORES PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of SENORES PHARMACEUTICALS


PE Ratio Performance Analysis for SENORES PHARMACEUTICALS

- SENORES PHARMACEUTICALS 's latest p/e ratio is 48.13x.

- SENORES PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 11.26x.

- SENORES PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, SENORES PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 45.04x.

- SENORES PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does SENORES PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SENORES PHARMACEUTICALS 121.5548.135,849.9
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5038.63446,792.0
DIVIS LABORATORIES LTD2,568.0069.37178,152.0
TORRENT PHARMACEUTICALS LTD2,138.0071.52152,915.0
CIPLA LTD3,869.7930.07116,354.0
DR REDDYS LABORATORIES LTD4,144.2027.19112,681.0
MANKIND PHARMA LTD1,926.4152.76101,632.0
LUPIN LTD5,355.4720.00107,091.0
ZYDUS LIFESCIENCES LTD5,026.4021.86109,875.0
AUROBINDO PHARMA LTD3,501.4525.5589,468.4
LAURUS LABS LTD889.8588.0778,368.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SENORES PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.00x
Max industry PE 88.07x
Median industry PE 38.63x
Average industry PE 44.83x



You may also like the below Video Courses